Still not fully convinced that that Hervaxx is a lost cause - but have read some interesting posts on the subject over the last few days to the contrary. No rose coloured glasses for Hervaxx but anything could happen to bring it back into play.
One thing is for certain, IMU has a number of arrows in its quiver, so it is not reliant totally on one product. One of the true drawcards to IMU IMHO.
Enough to focus on with its other plays.
Ann: Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA, page-103
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.2¢ | 4.9¢ | $1.384M | 27.31M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1302118 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 528865 | 4 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |